7MeERT Enhances Antibody-Drug Conjugate Efficacy in Glioblastoma by Inducing AMPK-p38MAPK-Mediated Non-Canonical Endocytosis of EGFRvIII
{{output}}
Introduction: Antibody-drug conjugates (ADCs) targeting EGFR variant III (EGFRvIII) hold promise for glioblastoma therapy, but clinical efficacy is limited by poor receptor internalization. ... ...
